CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Tesaro, Inc.  (TSRO)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

TSRO's Revenue Year on Year Growth by Quarter and Year

Tesaro,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
TSRO Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 4.23 0.23 -
III Quarter September - 3.73 0.09 -
II Quarter June 29.46 36.56 - -
I Quarter March 3.07 0.31 - -
FY   32.53 44.83 0.32 -

Financial Statements
Tesaro,'s second quarter 2017 Revenue $ 29.46 millions TSRO's Income Statement
Tesaro,'s second quarter 2016 Revenue $ 36.56 millions Quarterly TSRO's Income Statement
TSRO's Growth by Division See TSRO's Growth by Segment

TSRO Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 1739.13 % - -
III Quarter September - 4044.44 % - -
II Quarter June -19.41 % - - -
I Quarter March 890.32 % - - -
FY   - 13909.38 % - -



TSRO Revenue Growth Comment
Tesaro, Inc. reported decline in Revenue in the second quarter by -19.41% to $ 29.46 millions, from the same quarter in 2016.
This represents worst decline in recent Company history.

Looking into second quarter results within Major Pharmaceutical Preparations industry 93 other companies have achieved higher Revenue growth. While Tesaro, Inc.' s Revenue fall of -19.41% ranks overall at the positon no. 3007 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #94
Healthcare Sector #359
Overall #3007
Revenue Y/Y Growth Statistics
High Average Low
4187.36 % 1701.47 % -19.41 %
(Sep 30 2016)   (Jun 30 2017)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TSRO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for TSRO's Competitors
Revenue Growth for Tesaro,'s Suppliers
Revenue Growth for TSRO's Customers

You may also want to know
TSRO's Annual Growth Rates TSRO's Profitability Ratios TSRO's Asset Turnover Ratio TSRO's Dividend Growth
TSRO's Roe TSRO's Valuation Ratios TSRO's Financial Strength Ratios TSRO's Dividend Payout Ratio
TSRO's Roa TSRO's Inventory Turnover Ratio TSRO's Growth Rates TSRO's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Fate Therapeutics Inc -0.10 %$ -0.097 millions
Psychemedics Corp -0.17 %$ -0.165 millions
Halyard Health, Inc. -0.20 %$ -0.200 millions
Xtant Medical Holdings, Inc. -0.25 %$ -0.249 millions
Ocular Therapeutix, Inc. -0.68 %$ -0.680 millions
Emergent Biosolutions Inc. -0.70 %$ -0.705 millions
Tenet Healthcare Corp -0.90 %$ -0.900 millions
Genmark Diagnostics, Inc. -1.22 %$ -1.223 millions
Trovagene, Inc. -1.34 %$ -1.343 millions
Mymetics Corp -1.86 %$ -1.858 millions
Vaso Corp -1.98 %$ -1.982 millions
Recro Pharma, Inc. -2.00 %$ -1.997 millions
Inc Research Holdings, Inc. -2.13 %$ -2.130 millions
Quorum Health Corporation -2.16 %$ -2.165 millions
China Biologic Products Holdings, Inc. -2.34 %$ -2.344 millions
Msa Safety Incorporated -2.44 %$ -2.440 millions
Pacific Biosciences Of California, Inc. -3.25 %$ -3.249 millions
T2 Biosystems, Inc. -3.43 %$ -3.434 millions
Therapeuticsmd, Inc. -3.47 %$ -3.470 millions
Harvard Bioscience Inc -3.53 %$ -3.532 millions
Twinlab Consolidated Holdings, Inc. -3.61 %$ -3.614 millions
Acceleron Pharma Inc -4.32 %$ -4.319 millions
Conformis Inc -4.39 %$ -4.391 millions
Endologix Inc -4.74 %$ -4.744 millions
Steris Plc -4.76 %$ -4.764 millions
China Senior Living Industry International Holding -4.88 %$ -4.883 millions
Becton Dickinson & Co -5.10 %$ -5.097 millions
Cancer Genetics, Inc -5.67 %$ -5.671 millions
Brookdale Senior Living Inc. -5.75 %$ -5.748 millions
Cord Blood America, Inc. -5.91 %$ -5.907 millions